CEFTRIAXONE injection, powder, for solution

দেশ: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

CEFTRIAXONE SODIUM (UNII: 023Z5BR09K) (CEFTRIAXONE - UNII:75J73V1629)

থেকে পাওয়া:

WG Critical Care, LLC

INN (আন্তর্জাতিক নাম):

CEFTRIAXONE SODIUM

রচনা:

CEFTRIAXONE 10 g in 100 mL

প্রশাসন রুট:

INTRAVENOUS

প্রেসক্রিপশন টাইপ:

PRESCRIPTION DRUG

থেরাপিউটিক ইঙ্গিত:

Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection, USP and other antibacterial drugs, Ceftriaxone for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ceftriaxone for Injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: LOWER RESPIRATORY TRACT INFECTIONS caused

পণ্য সারাংশ:

Ceftriaxone for Injection, USP is available in Pharmacy Bulk Packages containing 10 g equivalent of ceftriaxone NDC 44567-703-01 (carton of 1). NOT FOR DIRECT ADMINISTRATION. OTHER PAC KAGE SIZES AVAILABLE : Ceftriaxone for injection, USP is also available as follows: Vials containing 500 mg equivalent of ceftriaxone. NDC 44567-700-25 (carton of 25). Vials containing 1 g equivalent of ceftriaxone. NDC 44567-701-25 (carton of 25). Vials containing 2 g equivalent of ceftriaxone. NDC 44567-702-25 (carton of 25). NOTE: Ceftriaxone for injection, USP sterile powder should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] and protected from light. Sterile, Non Pyrogenic, Preservative-Free. The container closure is not made with natural rubber latex.

অনুমোদন অবস্থা:

Abbreviated New Drug Application

পণ্য বৈশিষ্ট্য

CEFTRIAXONE- CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION
WG CRITICAL CARE, LLC
----------
CEFTRIAXONE FOR INJECTION, USP
PHARMACY BULK PACKAGE
NOT FOR DIRECT INFUSION
RX ONLY
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of
ceftriaxone for injection and other antibacterial drugs, ceftriaxone
for injection should be
used only to treat or prevent infections that are proven or strongly
suspected to be
caused by bacteria.
DESCRIPTION
Ceftriaxone for Injection, USP is a sterile, semisynthetic,
broad-spectrum cephalosporin
antibiotic for intravenous or intramuscular administration.
Ceftriaxone sodium is
(6_R_,7_R_)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-
5,6-dioxo-_as_-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic
acid, 7 -(_Z_)-(_O_-methyloxime), disodium salt, sesquaterhydrate.
The chemical formula of ceftriaxone sodium is C
H
N Na O S ·3.5H O. It has a
calculated molecular weight of 661.60 and the following structural
formula:
Ceftriaxone for Injection, USP is a white to yellowish-orange
crystalline powder which is
readily soluble in water, sparingly soluble in methanol and very
slightly soluble in ethanol.
The pH of a 1% aqueous solution is approximately 6.7. The color of
Ceftriaxone for
Injection, USP solutions ranges from light yellow to amber, depending
on the length of
storage, concentration and diluent used.
Each Pharmacy Bulk Package is supplied as a dry powder in bottles
containing sterile
ceftriaxone sodium, USP equivalent to 10 grams of ceftriaxone and is
intended for
intravenous infusion only. Ceftriaxone for Injection, USP contains
approximately 83 mg
(3.6 mEq) of sodium per gram of ceftriaxone activity.
A Pharmacy Bulk Package is a container of a sterile preparation for
parenteral use that
contains many single doses. The contents are intended for use in a
pharmacy admixture
program and are restricted to the preparation of admixtures for
intravenous infusion.
FURTHER DILUTION IS REQUIRED BEFORE USE